Freelance Science And Medical Journalist
James Kingsland is a freelance science and medical journalist. He specializes in topics such as MLD, dementia, lung cancer, exercise, and aging, while also exploring the neuroscience of meditation and altered states of consciousness through his books, Siddhartha’s Brain and Am I Dreaming?. His work has been featured in Freethink, HSJ Local, and Medical News Today.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United Kingdom (National)
Not enough data
James Kingsland's coverage primarily focuses on health and scientific topics, such as MLD, dementia, lung cancer, exercise, and aging. He frequently cites data in his articles. To pitch to James effectively, consider providing access to credible and recent studies or experts with in-depth knowledge of the specific topics he covers.
Given that he often delves into detailed research findings related to health and science, pitching a story that includes new groundbreaking research or innovative treatment methods within these areas may be well received by him.
Since James does not have a geographic focus specified for his coverage area, pitches can come from various locations globally as long as they are relevant to the topics he covers.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Paul Batchelor, James Kingsland
While the NHS Neighbourhood Programme marks a welcome step towards addressing health inequalities, it risks repeating past mistakes unless it abandons centrally prescribed solutions and truly empowers local communities
People with schizophrenia may be more likely to develop Parkinson’s, despite the two having opposite effects on the brain's dopamine system. Learn more here.
A new phase 3 clinical trial of the drug osimertinib has found that it could improve survival rates following surgery for non-small cell lung cancer by preventing metastasis.
An animal study suggests that fasting may negatively affect the immune system.
People with schizophrenia may be more likely to develop Parkinson’s, despite the two having opposite effects on the brain's dopamine system. Learn more here.
A new phase 3 clinical trial of the drug osimertinib has found that it could improve survival rates following surgery for non-small cell lung cancer by preventing metastasis.
An animal study suggests that fasting may negatively affect the immune system.
